Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers

MLA

Hashem B. El-Serag, et al. “Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.” American Journal of Gastroenterology, vol. 111, Dec. 2016, pp. 1778–87. EBSCOhost, https://doi.org/10.1038/ajg.2016.440.

APA

Hashem B. El-Serag, Shailesh Advani, Richa Shukla, Jun Ying, Yumei Cao, Fasiha Kanwal, Jennifer R. Kramer, Aylin Tansel, & Annette Walder. (2016). Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. American Journal of Gastroenterology, 111, 1778–1787. https://doi.org/10.1038/ajg.2016.440

Chicago

Hashem B. El-Serag, Shailesh Advani, Richa Shukla, Jun Ying, Yumei Cao, Fasiha Kanwal, Jennifer R. Kramer, Aylin Tansel, and Annette Walder. 2016. “Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.” American Journal of Gastroenterology 111 (December): 1778–87. doi:10.1038/ajg.2016.440.